Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

134 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antithrombotic effect of two low molecular weight thrombin inhibitors and a low-molecular weight heparin in a caval vein thrombosis model in the rat.
Eriksson BI, Carlsson S, Halvarsson M, Risberg B, Mattsson C. Eriksson BI, et al. Among authors: mattsson c. Thromb Haemost. 1997 Nov;78(5):1404-7. Thromb Haemost. 1997. PMID: 9408027
Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits.
Holmer E, Mattsson C, Nilsson S. Holmer E, et al. Among authors: mattsson c. Thromb Res. 1982 Mar 15;25(6):475-85. doi: 10.1016/0049-3848(82)90089-5. Thromb Res. 1982. PMID: 7112507
Coronary thrombosis/thrombolysis in pigs: effects of heparin, ASA, and the thrombin inhibitor inogatran.
Uriuda Y, Wang QD, Hatori N, Nordlander R, Sjöquist PO, Mattsson C, Rydén L. Uriuda Y, et al. Among authors: mattsson c. J Pharmacol Toxicol Methods. 1998 Mar;39(2):81-9. doi: 10.1016/s1056-8719(98)00006-9. J Pharmacol Toxicol Methods. 1998. PMID: 9694166
Pharmacokinetics of heparin and low molecular weight heparin fragment (Fragmin) in rabbits with impaired renal or metabolic clearance.
Palm M, Mattsson C. Palm M, et al. Among authors: mattsson c. Thromb Haemost. 1987 Oct 28;58(3):932-5. Thromb Haemost. 1987. PMID: 2829379
Pharmacokinetics of fragmin. A comparative study in the rabbit of its high and low affinity forms for antithrombin.
Palm M, Mattsson C. Palm M, et al. Among authors: mattsson c. Thromb Res. 1987 Oct 1;48(1):51-62. doi: 10.1016/0049-3848(87)90345-8. Thromb Res. 1987. PMID: 2827340
Antithrombotic effects of heparin oligosaccharides.
Mattsson C, Palm M, Söderberg K, Holmer E. Mattsson C, et al. Ann N Y Acad Sci. 1989;556:323-32. doi: 10.1111/j.1749-6632.1989.tb22514.x. Ann N Y Acad Sci. 1989. PMID: 2735663
Pharmacokinetic properties of size-homogeneous heparin oligosaccharides.
Palm M, Wu H, Mattsson C, Ansari A. Palm M, et al. Among authors: mattsson c. Thromb Res. 1990 Aug 15;59(4):799-805. doi: 10.1016/0049-3848(90)90062-h. Thromb Res. 1990. PMID: 1964251 No abstract available.
Bleeding times in rats treated with heparin, heparin fragments of high and low anticoagulant activity and chemically modified heparin fragments of low anticoagulant activity.
Palm M, Mattsson C, Svahn CM, Weber M. Palm M, et al. Among authors: mattsson c. Thromb Haemost. 1990 Aug 13;64(1):127-32. Thromb Haemost. 1990. PMID: 2177229
Antithrombotic activity of inogatran, a new low-molecular-weight inhibitor of thrombin, in a closed-chest porcine model of coronary artery thrombosis.
Uriuda Y, Wang QD, Grip L, Rydén L, Sjöquist PO, Mattsson C. Uriuda Y, et al. Among authors: mattsson c. Cardiovasc Res. 1996 Aug;32(2):320-7. doi: 10.1016/0008-6363(96)00114-9. Cardiovasc Res. 1996. PMID: 8796119
Effect of different types of thrombin inhibitors on thrombin/thrombomodulin modulated activation of protein C in vitro.
Mattsson C, Menschik-Lundin A, Nylander S, Gyzander E, Deinum J. Mattsson C, et al. Thromb Res. 2001 Dec 15;104(6):475-86. doi: 10.1016/s0049-3848(01)00392-9. Thromb Res. 2001. PMID: 11755958
134 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page